Microclinic Social Induction Pilot Intervention for Diabetes and Obesity Management in Qatar

Microclinic International

Status: Completed

Conditions: Diabetes Mellitus, Type II; Hypertension; Social Change; Overweight and Obesity; Behavioral Lifestyle Change

Treatments: Behavioral: Microclinic Social Induction Diabetes and Obesity Program

Study type: Interventional

Funder types: Other

Identifiers

NCT02175537

NPRP2014-2017

Details and patient eligibility

About

The purpose of the study is to pilot-phase test the effectiveness of the microclinic social induction model and its effects on behavioral and metabolic outcomes in different levels of social and familial relationships in Qatar. The investigators novel microclinic model is based on the principle that both healthy and unhealthy behaviors spread through preexisting social networks. A microclinic is a small group of approximately 2-8 friends or family members who are taught to modify their own behaviors as well as the behaviors of those around them, with a particular focus on the four "M's": Meals, Movement, Monitoring, and Medication. More than social support groups or peer-to-peer interventions, the microclinic model is unique in its focus on the long-term propagation of healthy behaviors throughout a participant's entire social network. Qatar is uniquely positioned (with its central geographic location in the Gulf region and its leadership in science and education) to spearhead a regional intervention focused on managing and preventing diabetes in the Gulf region.

Full description

This pilot study, "Microclinic Social Induction Intervention for Diabetes and Obesity Management in Qatar," is a two-arm randomized controlled trial of a 7-week condensed intervention to evaluate the efficacy of the microclinic social induction model on propagating lifestyle changes and in improving glycemic and metabolic control in Doha, Qatar.

The microclinic social induction model leverages different levels of social and familial relationships to positively influence behaviors relating to diabetes and other metabolic conditions through small treatment units called 'microclinic groups,' consisting of 2-8 peers and family members of the same social network. The intervention model brings microclinic groups to a larger classroom network (~25 people/class) where each class shares access to a culturally salient diabetes educational curriculum and group support to promote health behavior changes such as improvement in diet, exercise, medication adherence, and blood pressure management to then influence better glycemic and metabolic control.

Enrollment: 64 patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Over 18 years old
• Mentally competent
• Body Mass Index of 30 or higher
• Body Mass Index of 25 or higher and self-reported pre-diabetes or type II diabetes

Exclusion criteria

• They do not meet the above criteria
• They are pregnant
• They have significant medical complications that prevent them from making changes to diet or level of physical activity.

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

64 participants in 2 patient groups

Microclinic social induction training

Experimental group

Description:

BMI of 30 and over; or BMI of 25 and over and self-reported pre-diabetes or type II diabetes will receive the Microclinic Social Induction Diabetes and Obesity Program. The intervention is a training on diabetes self-management, disease monitoring, diabetes prevention, prevention of complications, health behavior change, and social network supports in order to improve chronic disease risk factors.

Treatment:

Behavioral: Microclinic Social Induction Diabetes and Obesity Program

Controls

No Intervention group

Description:

Receiving no intervention but parallel primary and secondary outcome measures as intervention study arm